PDSB Company Profile and Key Details
PDS Biotechnology Corporation
PDSB Stock Price Chart
Stock Price Today
PDS Biotechnology Corporation (PDSB) stock surged +11.41%, trading at $1.66 on NASDAQ, up from the previous close of $1.49. The stock opened at $1.47, fluctuating between $1.45 and $1.72 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.
Company Information
| Employees | 25 |
| Beta | 1.93 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
PDS Biotechnology Corporation (NASDAQ: PDSB) stock price is $1.66 in the last trading session. During the trading session, PDSB stock reached the peak price of $1.72 while $1.45 was the lowest point it dropped to. The percentage change in PDSB stock occurred in the recent session was 11.41% while the dollar amount for the price change in PDSB stock was $0.17.
The NASDAQ listed PDSB is part of Biotechnology industry that operates in the broader Healthcare sector. PDS Biotechnology Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Sanjay Zaveri
Senior Vice President of Bus. Devel.
Ms. Lauren V. Wood M.D.
Chief Medical Officer
Mr. Spencer Brown J.D.
Senior Vice President & Gen. Counsel
Dr. Gregory L. Conn Ph.D.
Chief Scientific Officer
Dr. Joe J. Dervan
Vice President of R&D
Dr. Frank K. Bedu-Addo Ph.D.
Pres, Chief Executive Officer & Director
Ms. Nathalie Riebel
Senior Vice President of Clinical Operations
Ms. Deanne Randolph
Vice President of Commercial Devel. & Head of Investor Relations
Mr. Matthew C. Hill CPA
Chief Financial Officer, Principal Financial & Accounting Officer
Ms. Janetta Trochimiuk
Controller
PDSB's closing price is 14.44% higher than its 52-week low of $1.30 where as its distance from 52-week high of $6.68 is -77.69%.
Number of PDSB employees currently stands at 25.
Official Website of PDSB is: https://www.pdsbiotech.com
PDSB could be contacted at phone 800 208 3343 and can also be accessed through its website. PDSB operates from 25B Vreeland Road, Florham Park, NJ 07932, United States.
PDSB stock volume for the day was 419.56K shares. The average number of PDSB shares traded daily for last 3 months was 410.33K.
The market value of PDSB currently stands at $62.10M with its latest stock price at $1.66 and 37.41M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com